SIMULATIONS PLUS
Simulations Plus is a developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) and Physiologically-Based Pharmacokinetic (PBPK) modeling and simulation software for the pharmaceutical and biotechnology, generics, chemical, cosmetic, and food ingredient industries today. Our software allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research & development costs and helping clients make better projects dec... isions... sooner. Founded in 1996, Simulations Plus employs over 60 employees and is publicly-traded on the NASDAQ stock exchange (ticker symbol = SLP).Our headquarters are based in Lancaster, California, with our pharmacometrics consulting team located in Buffalo, New York. Trusted distributors handle sales and scientific support in Asian territories. 19 of the top 20 pharmaceutical companies, plus numerous mid- and small-sized companies and all major regulatory agencies, license our modeling & simulation technology.
SIMULATIONS PLUS
Industry:
Biotechnology Computer Data Mining Enterprise Software Information Technology Life Science Software
Founded:
1996-01-01
Address:
Lancaster, California, United States
Country:
United States
Website Url:
http://www.simulations-plus.com
Total Employee:
51+
Status:
Active
Contact:
(661)723-7723
Email Addresses:
[email protected]
Total Funding:
1.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager WordPress Domain Not Resolving Sitelinks Search Box Organization Schema Yoast WordPress SEO Plugin ReCAPTCHA
Similar Organizations
Anchore
Anchore helps organizations implement secure container-based workflows without compromising velocity.
DataZymes
Catalyzing Innovation in Pharma with Data-driven Digital Products
Font Awesome
Font Awesome is always getting a little awesome-er.
Genospace
Genospace is a medicine software platform that genomics is driving the development of precision medicine.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-04-03 | Lixoft | Lixoft acquired by Simulations Plus | 16.5 M USD |
| 2017-05-01 | DILIsym Services | DILIsym Services acquired by Simulations Plus | N/A |
| 2014-07-24 | Cognigen | Cognigen acquired by Simulations Plus | 7 M USD |
| 2005-11-04 | Bioreason | Bioreason acquired by Simulations Plus | N/A |
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Simulations Plus
U.S. Food and Drug Administration
U.S. Food and Drug Administration investment in Grant - Simulations Plus
Official Site Inspections
http://www.simulations-plus.com Semrush global rank: 2.37 M Semrush visits lastest month: 7.78 K
- Host name: 23.185.0.1
- IP address: 23.185.0.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Simulations Plus"
Simulations Plus - Wikipedia
Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity (ADMET) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services. See details»
Simulations Plus
Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. ...See details»
Simulations Plus - Crunchbase Company Profile
Simulations Plus acquired Pro-ficiency, creating a unique platform spanning the drug development continuum. The company made a $100M acquisition and launched a corporate development initiative. Simulations Plus shares received …See details»
Simulations Plus Team
Simulations Plus, Inc. Manas Shah Director, Sim. Technologies Physiologically Based Pharmacokinetics (PBPK) Solutions Kai Shen Senior Scientist Physiologically Based …See details»
Simulations Plus, Inc. - AnnualReports.com
Simulations Plus, Inc. (NASDAQ: SLP) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, development research and regulatory submissions. They partner with …See details»
Simulations Plus - The Org
Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial …See details»
Simulations Plus, Inc. - LinkedIn
Simulations Plus, Inc. | 9,169 followers on LinkedIn. Where are you in the drug development process? Save resources & get to market faster with our solutions! | Simulations Plus is a …See details»
Simulations Plus Company Profile - Office Locations ... - Craft
Oct 29, 2024 Simulations Plus, Inc. is a developer of drug discovery and development software for mechanistic modeling and simulation, for machine-learning-based prediction of properties …See details»
Simulations Plus - Funding, Financials, Valuation & Investors
Simulations Plus is registered under the ticker NASDAQ:SLP . Their stock opened with $5.00 in its May 13, 2021 IPO. Simulations Plus is funded by 2 investors. U.S. Food and Drug …See details»
Simulations Plus - Overview, News & Similar companies - ZoomInfo
Jul 9, 2024 Simulations Plus contact info: Phone number: (661) 723-7723 Website: www.simulations-plus.com What does Simulations Plus do? Simulations Plus, Inc. develops …See details»
Simulations Plus - Contacts, Employees, Board Members
Organization. Simulations Plus . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 7. Number of …See details»
Simulations Plus - Owler
Simulations Plus’s Profile, Revenue and Employees. Simulations Plus is a California-based firm that designs software products offering solutions such as biosimulation and toxicity modeling …See details»
Simulations Plus Optimizes Business Unit Structure to Support …
Aug 23, 2024 Contacts. Investor Relations Contacts: . Lisa Fortuna Financial Profiles 310-622-8251 [email protected] Renee Bouche Simulations Plus Investor Relations 661-723-7723 …See details»
What is Simulations Plus? Company Culture, Mission, Values
Serving clients worldwide for 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, …See details»
Working at Simulations Plus - Glassdoor
Serving clients worldwide for 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, …See details»
Simulations Plus (NASDAQ:SLP) Will Be Hoping To Turn Its Returns …
8 hours ago In terms of Simulations Plus' historical ROCE movements, the trend isn't fantastic. Over the last five years, returns on capital have decreased to 4.7% from 26% five years ago.See details»
Overview - Simulations Plus
For Simulations Plus clients, our experts are able to offer: machine learning to assist with drug design efforts; bridge physiologically based pharmacokinetic and biopharmaceutics modeling …See details»
Experiential Simulation - Simulations Plus
Experience our simulation-enabled methodology with engaging, immersive content tailored to your project’s learning needs. From rapid filmed content for soft skills to dynamic scientific …See details»
Welcome to Pro-ficiency - Simulations Plus
Pro-ficiency is now part of Simulations Plus. By joining forces, we are excited to expand our support and ability to optimize every stage of your drug development—from discovery, through …See details»
Resource Center - Simulations Plus
Cookie Duration Description; cookielawinfo-checkbox-analytics: 11 months: This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in …See details»